Preclinical study and phase 2 trial of neoadjuvant pyrotinib combined with chemotherapy in luminal/HER2-low breast cancer: PILHLE-001 study
吡咯替尼联合化疗治疗管腔内/HER2-low乳腺癌的临床前研究及Ⅱ期临床试验:PILHLE-001研究
期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2024.101807
Chang Gong, Yuan Xia, Yingying Zhu, Yaping Yang, Qun Lin, Qiang Liu, Wenqian Yang, Li Ling, Jiajie Zhong, Zhuxi Duan, Yunjie Zeng, Ziliang Cheng, Jun Shen, Yinduo Zeng, Louis Wing Cheong Chow, Erwei Song